我院2009年—2010年中药注射液用药分析  

Analysis of Drug Use of Traditional Chinese Medicine Injection During 2009—2010

作　　者：李婷婷[1] 刘海燕[1] 

机构地区：[1]西双版纳州人民医院,云南景洪666100

出　　处：《大理学院学报（综合版）》2011年第8期21-23,共3页Journal of Dali University

摘　　要：目的:了解我院2009年—2010年中药注射液的使用情况及发展趋势,为临床合理用药提供参考。方法:对我院2009年—2010年中药注射剂使用的种类、销售金额、用药频度等数据进行统计分析。结果:2009年和2010年中药注射剂分别占总药品销售金额的16.92%和14.75%,排在销售金额前20位的中药注射液品种变化不大,大部分为心血管疾病药物。DDDs综合排序前3位的为细辛脑、薄芝糖肽、丹参酮IIA磺酸钠。结论:我院中药注射剂增长缓慢,但用药率仍高,应进一步规范管理。Objective： To investigate the drug use and the trend of traditional Chinese medicine injection（CMI） in our hospital during the period of 2009-2010 and to provide references for clinical rational drug use.Methods： The data concerning the species,consumption sum and frequency of the drug use of CMI in our hospital from 2009 to 2010 were collected and statistically analyzed.Results： The consumption sum of CMI accounted for 16.92% and 14.75% among the total drug sales amount in 2009 and 2010 respectively.The top 20 CMI on the consumption sum list changed little during the two yeas,and the majority was used for cardiovascular diseases.Integrated,asarone,Bozhi glycopeptide,tanshinone IIA sulfonate were the first three on the list of DDDs.Conclusions： The DDDs of CMI in our hospital was high despite of a slow growth of CMI.Great efforts should be attached to standard management of injection for Chinese medicines.

关 键 词：中药注射液 销售金额 用药频度 药物不良反应 

分 类 号：R951[医药卫生—药学]